{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T01:50:33Z","timestamp":1648605033702},"reference-count":36,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medicina Cl\u00ednica"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.medcli.2016.01.008","type":"journal-article","created":{"date-parts":[[2016,3,5]],"date-time":"2016-03-05T23:15:26Z","timestamp":1457219726000},"page":"76-80","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cuando la informaci\u00f3n para los participantes de un ensayo de efectividad comparativa acaba en los tribunales: \u00bfse abre la caja de Pandora?"],"prefix":"10.1016","volume":"147","author":[{"given":"Rafael","family":"Dal-R\u00e9","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F\u00e9lix","family":"Ome\u00f1aca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diego","family":"Gracia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.medcli.2016.01.008_bib0005","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1056\/NEJMoa0911781","article-title":"Target ranges of oxygen saturation in extremely preterm infants","volume":"362","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.medcli.2016.01.008_bib0010","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1056\/NEJMe1304996","article-title":"Informed consent and SUPPORT","volume":"368","author":"Drazen","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.medcli.2016.01.008_bib0015","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.medcli.2015.01.028","article-title":"La historia cl\u00ednica electr\u00f3nica en los ensayos cl\u00ednicos de efectividad con medicamentos integrados en la pr\u00e1ctica cl\u00ednica","volume":"145","author":"Carcas","year":"2015","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.medcli.2016.01.008_bib0020","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1056\/NEJMp1306986","article-title":"In support of SUPPORT--A view from the NIH","volume":"368","author":"Hudson","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.medcli.2016.01.008_bib0025","unstructured":"Buchanan L. Human research protections under federalwide assurance (FWA) 5960. March 7, 2013 [consultado 30 Dic 2015]. Disponible en: http:\/\/www.hhs.gov\/ohrp\/detrm_letrs\/YR13\/mar13a.pdf"},{"key":"10.1016\/j.medcli.2016.01.008_bib0030","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1056\/NEJMc1304827","article-title":"Oxygen saturation targets in extremely preterm infants","volume":"368","author":"Carlo","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.medcli.2016.01.008_bib0035","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1056\/NEJMp1305086","article-title":"Risk, consent, and SUPPORT","volume":"368","author":"Magnus","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.medcli.2016.01.008_bib0040","doi-asserted-by":"crossref","first-page":"e36","DOI":"10.1056\/NEJMc1307008","article-title":"The OHRP and SUPPORT","volume":"368","author":"Wilfond","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.medcli.2016.01.008_bib0045","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1056\/NEJMc1308015","article-title":"The OHRP and SUPPORT--Another view","volume":"369","author":"Macklin","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.medcli.2016.01.008_bib0050","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/15265161.2013.849303","article-title":"Informed consent and standard of care:What must be disclosed","volume":"13","author":"Macklin","year":"2013","journal-title":"Am J Bioeth"},{"key":"10.1016\/j.medcli.2016.01.008_bib0055","unstructured":"The Editorial Board. An ethical breakdown. The New York Times, April 15, 2013 [consultado 30 Dic 2015]. Disponible en: http:\/\/www.nytimes.com\/2013\/04\/16\/opinion\/an-ethical-breakdown-in-medical-research.html"},{"key":"10.1016\/j.medcli.2016.01.008_bib0060","unstructured":"Carome MA, Wolfe SM, Macklin R. The Surfactant, Positive Pressure, and Oxygenation Randomized Trial (SUPPORT). Analysis of the complete protocol and complete consent form. Public Citizen, May 8, 2013 [consultado 30 Dic 2015]. Disponible en: http:\/\/www.citizen.org\/documents\/2124.pdf"},{"key":"10.1016\/j.medcli.2016.01.008_bib0065","doi-asserted-by":"crossref","first-page":"f4637","DOI":"10.1136\/bmj.f4637","article-title":"The US Office for Human Research Protections\u2019 judgment of the SUPPORT trial seems entirely reasonable","volume":"347","author":"Pharoah","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.medcli.2016.01.008_bib0070","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/j.jpeds.2013.08.061","article-title":"OHRP and SUPPORT: Lessons in balancing safety and improving the way we care for patients","volume":"163","author":"Wright","year":"2013","journal-title":"J Pediatr"},{"key":"10.1016\/j.medcli.2016.01.008_bib0075","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/500377a","article-title":"Subject to question","volume":"500","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.medcli.2016.01.008_bib0080","unstructured":"Buchanan L. Human research protections under federal wide assurance (FWA) 5960. June 4, 2013 [consultado 30 Dic 2015]. Disponible en: http:\/\/www.mazzaschi.com\/OHRP.6.4.2013.pdf"},{"key":"10.1016\/j.medcli.2016.01.008_bib0085","unstructured":"U. S. Department of Health and Human Services. OHRP. Draft guidance on disclosing reasonably foreseeable risks in research evaluating standards of care. October 20, 2014 [consultado 30 Dic 2015]. Disponible en: http:\/\/www.hhs.gov\/ohrp\/newsroom\/rfc\/comstdofcare.html"},{"key":"10.1016\/j.medcli.2016.01.008_bib0090","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1056\/NEJMhle1413301","article-title":"The concept of risk in comparative-effectiveness research","volume":"371","author":"Lantos","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.medcli.2016.01.008_bib0095","unstructured":"Yu PP. ASCO expresses concern about OHRP draft guidance on research risk disclosure. December 23, 2014. Docket ID Number HHS-OPHS-2014-0005 OHRP Draft Guidance on Disclosing Reasonably Foreseeable Risks Research Evaluating Standards of Care [consultado 30 Dic 2015]. Disponible en: http:\/\/www.asco.org\/advocacy\/asco-expresses-concern-about-ohrp-draft-guidance-research-risk-disclosure"},{"key":"10.1016\/j.medcli.2016.01.008_bib0100","unstructured":"Carome MA, Wolfe SM. Docket HHS-OPHS-2014-0005, draft guidance on disclosing reasonably foreseeable risks in research evaluating standards of care (79 FR 63629). October 24, 2014 [consultado 30 Dic 2015]. Disponible en: http:\/\/www.citizen.org\/documents\/2237.pdf"},{"key":"10.1016\/j.medcli.2016.01.008_bib0105","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1056\/NEJMp1510876","article-title":"Vindication for SUPPORT","volume":"373","author":"Lantos","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.medcli.2016.01.008_bib0110","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1056\/NEJMe1511158","article-title":"Support for SUPPORT","volume":"373","author":"Drazen","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.medcli.2016.01.008_bib0115","unstructured":"Tavernise S. Premature babies study raises debate over risks and ethical consent. The New York Times. September 7, 2015 [consultado 30 Dic 2015]. Disponible en: http:\/\/www.nytimes.com\/2015\/09\/08\/health\/premature-babies-study-and-judges-ruling-raise-debate-over-consent.html"},{"key":"10.1016\/j.medcli.2016.01.008_bib0120","first-page":"53931","article-title":"Notice of Proposed Rulemaking","volume":"80","year":"2015","journal-title":"Fed Regist"},{"key":"10.1016\/j.medcli.2016.01.008_bib0125","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1002\/hast.407","article-title":"SUPPORT and the ethics of study implementation: Lessons for comparative effectiveness research from the trial of oxygen therapy for premature babies","volume":"45","author":"Lantos","year":"2015","journal-title":"Hastings Cent Rep."},{"issue":"12","key":"10.1016\/j.medcli.2016.01.008_bib0130","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1080\/15265161.2013.849304","article-title":"What are reasonably foreseeable risks?","volume":"13","author":"Resnik","year":"2013","journal-title":"Am J Bioeth"},{"issue":"12","key":"10.1016\/j.medcli.2016.01.008_bib0135","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1080\/15265161.2013.849310","article-title":"Personalized medicine in the NICU","volume":"13","author":"Barrington","year":"2013","journal-title":"Am J Bioeth"},{"key":"10.1016\/j.medcli.2016.01.008_bib0140","doi-asserted-by":"crossref","first-page":"f3786","DOI":"10.1136\/bmj.f3786","article-title":"How not to reduce uncertainties in care?","volume":"346","author":"Modi","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.medcli.2016.01.008_bib0145","unstructured":"European Medicines Agency. Guideline for Good Clinical Practice. ICH Topic E 6 (R1). July 2002. CPMP\/ICH\/135\/95 [consultado 30 Dic 2015]. Disponible en: http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Scientific_guideline\/2009\/09\/WC500002874.pdf"},{"key":"10.1016\/j.medcli.2016.01.008_bib0150","unstructured":"U. S. Department of Health and Human Services. Code of Federal Regulations. 45 CFR 46, Protections of human subjects [consultado 30 Dic 2015]. Disponible en: http:\/\/www.hhs.gov\/ohrp\/humansubjects\/guidance\/45cfr46.html"},{"key":"10.1016\/j.medcli.2016.01.008_bib0155","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1056\/NEJMhle1313674","article-title":"Informed consent, comparative effectiveness, and learning health care","volume":"370","author":"Faden","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.medcli.2016.01.008_bib0160","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1056\/NEJMhle1312508","article-title":"Informed consent for pragmatic trials--The integrated consent model","volume":"370","author":"Kim","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.medcli.2016.01.008_bib0165","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1001\/jama.2014.18528","article-title":"Varieties of standard-of-care treatment randomized trials: Ethical implications","volume":"313","author":"Kim","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.medcli.2016.01.008_bib0170","doi-asserted-by":"crossref","first-page":"690","DOI":"10.7326\/M15-0166","article-title":"Attitudes toward risk and informed consent for research on medical practices: A cross-sectional survey","volume":"162","author":"Cho","year":"2015","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.medcli.2016.01.008_bib0175","doi-asserted-by":"crossref","first-page":"356","DOI":"10.7326\/M15-0817","article-title":"Pragmatic randomized trials without standard informed consent: A national survey","volume":"163","author":"Nayak","year":"2015","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.medcli.2016.01.008_bib0180","unstructured":"Reglamento (UE) N.o 536\/2014 del Parlamento Europeo y del Consejo de 16 de abril de 2014 sobre los ensayos cl\u00ednicos de medicamentos de uso humano y por el que se deroga la Directiva 2001\/20\/CE. Diario Oficial de la Uni\u00f3n Europea, 27 de mayo de 2014. L158\/1-76 [consultado 30 Dic 2015]. Disponible en: http:\/\/eur-lex.europa.eu\/legal-content\/ES\/TXT\/PDF\/?uri=CELEX:32014R0536&from=ES"}],"container-title":["Medicina Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775316000427?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775316000427?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,14]],"date-time":"2018-09-14T10:54:51Z","timestamp":1536922491000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025775316000427"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["S0025775316000427"],"URL":"https:\/\/doi.org\/10.1016\/j.medcli.2016.01.008","relation":{},"ISSN":["0025-7753"],"issn-type":[{"value":"0025-7753","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cuando la informaci\u00f3n para los participantes de un ensayo de efectividad comparativa acaba en los tribunales: \u00bfse abre la caja de Pandora?","name":"articletitle","label":"Article Title"},{"value":"Medicina Cl\u00ednica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medcli.2016.01.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}